Exporting Cannabis to Switzerland from Canada: A 2026 B2B Guide for Licensed Producers

Switzerland sits outside the European Union. EU-GMP recognition and the Canada-EU Mutual Recognition Agreement do not apply here the way they do for German imports. Cannabis is governed instead by Switzerland's own Narcotics Act, known domestically as the Betaubungsmittelgesetz and administered by Swissmedic, which functions as the country's national Cannabis Agency.

Before 2022, a doctor who wanted to prescribe medical cannabis needed a case-by-case exception from the Federal Office of Public Health. That requirement is gone. Doctors can now prescribe directly. The Federal Office of Public Health has shifted its role toward issuing exception permits for research use and overseeing the country's non-medical cannabis pilot trials. Swissmedic, meanwhile, took over cultivation, manufacturing, processing, storage, distribution, import, and export licensing in full.

One classification detail matters more here than almost anywhere else Canadian LPs export to. Cannabis with a THC content of 1 percent or higher is a prohibited narcotic in Switzerland unless it moves under the medical framework. Canadian dried flower in the 15 to 30 percent THC range, including higher potency genetics such as AlphaLeaf's Ice Cream Cake at 30.3 percent THC, has no non-medical pathway into the country. Every shipment travels as a medical cannabis product. There is no secondary market to fall back on if the medical paperwork isn't in order.

Two authorizations have to exist before product moves. The Swiss buyer needs an operating licence covering the activity in question, whether that's cultivation, manufacture, processing, storage, distribution, import, or export. That licence runs on a five-year term. Separately, Swissmedic issues an import permit for each individual shipment, not a blanket annual approval that covers a year's worth of orders at once. On the Canadian side, the standard Health Canada export permit process still applies, the same pathway Canadian LPs already use for German and Australian shipments.

Before a Canadian LP commits to a Swiss partnership, a few things are worth confirming directly with the buyer rather than taking a licence number at face value, the same groundwork covered in our guide to vetting international cannabis importers:

• The operating licence is current and not mid-renewal when the first shipment is scheduled
• The licence scope explicitly covers finished dried flower rather than extracts or formulations alone
• The buyer can name a qualified responsible person for narcotics handling, a requirement Swissmedic checks during inspection
• Recent GMP or GDP inspection history is available on request

Swissmedic suspends or narrows licence scope more readily than some regulators do, so this isn't a one-time check done at contract signing. A partner's status at the start of a relationship doesn't guarantee the same status six months later, and a Canadian LP that assumes otherwise risks a shipment stalled at the border.

Swissmedic updated its Cannabis for Medical Purposes information sheet in 2026. The revision clarifies something that trips up new exporters: medical cannabis in Switzerland falls into one of three categories. It can be an active pharmaceutical ingredient, a non-ready-to-use intermediate product prepared under a formula magistralis, or a ready-to-use medicinal product. Trade in formula magistralis preparations is not permitted, and neither is importing or exporting them. That rules out one of the three categories immediately for a Canadian exporter.

In practice, Canadian dried flower enters Switzerland as an API. That status requires the Swiss importer to hold an operating licence that specifically authorizes handling controlled substances under the relevant schedule. It also shapes what documentation a Canadian LP needs to hand over before the first pallet ships. A certificate of analysis built around ISO/IEC 17025 accredited testing maps directly onto what Swissmedic reviews when it evaluates an API import. So does a GACP compliant cultivation record and full batch traceability. The documentation package a Canadian exporter already builds for Germany or Australia translates well here, with some relabeling for Swiss terminology rather than a rebuild from scratch.

AlphaLeaf ships every export order with this package built in from the start. Hand trimmed flower from the Montreal facility, batch level traceability, and ISO-certified lab results give a Swiss importer most of the paper trail up front. Export authorization under the Cannabis Act rounds it out. There's no separate documentation project required on either side once the relationship is underway. See AlphaLeaf's certifications for the full testing and compliance stack.

First shipments to a new Swiss partner tend to be modest. The market is small relative to Germany (see our country-by-country import comparison), and most Swiss buyers build prescribing volume gradually rather than stocking a large opening order. A five-year operating licence on the Swiss side sounds like long-term stability. But a 2026 case involving a Swiss pharmaceutical and medtech joint venture showed how much groundwork happens before a single import clears. The partner applying for its own narcotics licence was a prerequisite step, not a formality running in parallel with sourcing and negotiation.

That sequencing matters for how a Canadian LP should plan a Swiss market entry. A Swiss partner who is still finalizing their own Swissmedic licence isn't ready to receive product, regardless of how far contract negotiations have progressed. Confirming licence status is step one, not something to check after commercial terms are agreed. Treating it as a formality is the most common way Canadian exporters lose months on a Swiss deal that looked ready to close.

A realistic timeline also depends on how the Swiss partner structures their own supply chain. A buyer who already distributes other imported medicines through pharmacies has the operational pieces in place and mainly needs the product-specific import permit. A newer entrant building a cannabis-specific operation from the ground up, as in the 2026 joint venture case, needs considerably more runway before the first shipment can clear. For partnership inquiries, see AlphaLeaf's international page or get in touch.

Does Switzerland require a Swissmedic import permit for every cannabis shipment?

Yes. Switzerland issues import permits per shipment rather than as a blanket annual authorization, separate from the Swiss buyer's underlying operating licence.

Can Canadian flower above 1 percent THC be imported into Switzerland?

Only under the medical cannabis framework. Cannabis at or above 1 percent THC is a prohibited narcotic in Switzerland outside of medical use, so higher potency Canadian flower moves exclusively as a medical product through Swissmedic's authorization process.

What is the difference between an API and a finished medicinal product under Swiss cannabis rules?

An active pharmaceutical ingredient, or API, is unprocessed or minimally processed cannabis that a Swiss licence holder prepares further. A finished medicinal product is ready to dispense. A third category, formula magistralis intermediate preparations, cannot be traded, imported, or exported at all. Canadian dried flower typically enters Switzerland as an API.

Does Switzerland follow EU-GMP for imported cannabis?

No. Switzerland is not an EU member and runs its own licensing and GMP inspection system through Swissmedic, independent of the EU-GMP framework that governs German imports.

How long does Swiss import authorization typically take for a new Canadian supplier?

Timelines vary with how far along the Swiss partner's own operating licence is. That licence has to be in place before an import permit can even be requested. LPs working with a partner who already holds a current licence move faster than those entering a partnership where licensing is still underway.

Is a Canadian export permit still required alongside Swiss import authorization?

Yes. The standard Health Canada export permit process applies to Swiss shipments the same way it applies to German or Australian ones, in addition to the Swiss buyer's import permit.